AzTrials
AzTrials

Attention Deficit Disorder With Hyperactivity (ADHD)NCT07150078

Dual Task and Attention Deficit and Hyperactivity Disorder

An observational study of Attention Deficit Disorder With Hyperactivity (ADHD), run by Gaziantep Islam Science and Technology University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

When motor control deficits, sensory-perceptual deficits, and deficits in attention allocation and executive functions, often seen in ADHD, are accompanied by impairments in attentional allocation and executive function, further difficulties with dual tasks may arise. Read more about this study

Who is it for?
Ages 7 to 14 yearsHealthy volunteers can take part
What is being tested?
test
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2025to 15 Nov 2025
How long will I take part?
3 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Attention Deficit and Hyperactivity Disorder and Healthy Children

Who may be able to join

  • Being between the ages of 7 and 16,
  • having been diagnosed with ADHD,
  • volunteering to participate in the study, or having received parental consent.

Who cannot join

  • The individual is unwilling to participate in the study or does not have family consent.
  • The individual has another known neurological or orthopedic disease.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ipek Kırmacı

    Şehitkamil, Gaziantep, 544 261 82 85

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of Differences in Dual and Single Motor and Cognitive Tasks of Children With Attention Deficit and Hyperactivity Disorder Compared to Healthy Children

When motor control deficits, sensory-perceptual deficits, and deficits in attention allocation and executive functions, often seen in ADHD, are accompanied by impairments in attentional allocation and executive function, further difficulties with dual tasks may arise. The aim of this study was to compare the performance of children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) with healthy children on single-motor and dual-motor and motor-cognitive tasks.

Read the detailed description

Attention Deficit Hyperactivity Disorder (ADHD), characterized by inattention, hyperactivity, and impulsivity, is a heterogeneous neurodevelopmental disorder frequently encountered in childhood. Genetic, social, and physical factors play a significant role in ADHD, and it is known that it can cause problems in many areas, including financial costs, family responsibilities, academic performance, and physical and mental health. These children are fidgety, unable to sit still, boredom with sitting for long periods, constantly running or climbing in childhood, but as adults, they remain restless, often climbing walls, have difficulty engaging in quiet activities, begin speaking before the other person has even finished, interrupt others, talk excessively, and have difficulty with tasks that require waiting or taking turns. Hyperactivity is more common in these children during the preschool years. Other characteristics of these children include being stubborn, sleepy, bedwetting, and displaying anger and aggression in response to situations. Motor activity decreases with age. By adulthood, they experience emotional distress. Dual tasking, a common occurrence in daily life, is defined as the simultaneous performance of two tasks that can be performed independently, measured separately, and have different objectives. In dual tasking, motor-motor, motorcognitive, or cognitive-cognitive tasks are performed simultaneously. When motor control deficits, sensory-perceptual deficits, attention allocation, and executive function deficits frequently seen in ADHD coexist, further difficulties with dual tasks may arise.

Being tested
test
Keywords
dual task, motor performance, cognitive perfomance
Medical subject headings
Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • testDiagnostic test

    Descriptive tests will be applied

Study groups in NCT07150078
Study groupRoleWhat they receive
ADHDAttention Deficit Hyperactivity Disorder (ADHD): All tests will be applied to ADHD children.
Receives: Diagnostic Test: test
ControlHealthy Children: All tests will be applied to healthy children.
Receives: Diagnostic Test: test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nine hole peg test- Single task

    Participants are asked to place nine 3.2 cm long sticks into the holes on the platform as quickly as possible and then collect them. This process is timed and recorded in seconds.

    Measured: At Baseline

  2. Nine hole peg test-motor dual task

    Participants are asked to place nine 3.2 cm long sticks into the holes on the platform as quickly as possible and then collect them. This process is timed and recorded in seconds. Keeping pace with the foot during the 9-hole peg for motor-motor dual task (dorsi-plantar flexion)

    Measured: at baseline

  3. Nine hole peg test- congitive dual task

    Participants are asked to place nine 3.2 cm long sticks into the holes on the platform as quickly as possible and then collect them. This process is timed and recorded in seconds. During the 9-hole peg test for the motor-cognitive dual task, they will be asked to say animal names starting with the letter K.

    Measured: At baseline

  4. 10 meter walk test-single task

    The subject is asked to walk a 10-meter distance at a normal walking pace. To mitigate the effects of acceleration and deceleration, a 2-meter starting and finishing distance is included before and after the 10-meter test area. During the test, the timer starts when the subject's foot crosses the starting line and stops when the subject crosses the finishing line. Two measurements are taken, and the best value is recorded in m/s.

    Measured: at baseline

  5. Ten meter walk test- motor dual task

    The subject is asked to walk a 10-meter distance at a normal walking pace. To mitigate the effects of acceleration and deceleration, a 2-meter starting and finishing distance is included before and after the 10-meter test area. During the test, the timer starts when the subject's foot crosses the starting line and stops when the subject crosses the finishing line. Two measurements are taken, and the best value is recorded in m/s. For the motor-motor dual task, children will be asked to carry a tray containing an empty box with two hands during the 10-meter walking test.

    Measured: At baseline

  6. Ten meter walk test- cognitive dual task

    The subject is asked to walk a 10-meter distance at a normal walking pace. To mitigate the effects of acceleration and deceleration, a 2-meter starting and finishing distance is included before and after the 10-meter test area. During the test, the timer starts when the subject's foot crosses the starting line and stops when the subject crosses the finishing line. Two measurements are taken, and the best value is recorded in m/s. For the motor-cognitive dual task, children will be asked to say animal names starting with the letter K during the 10-meter walking test.

    Measured: at baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2025
  2. Study start1 Sep 2025
  3. Primary completion30 Oct 2025
  4. Study completion15 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
60 participants (actual)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07150078
Sponsor's protocol ID
ipekkirmaci.
Status last verified
Dec 2025
First submitted
25 Aug 2025
Last updated
12 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Attention Deficit Disorder With Hyperactivity (ADHD), run by Gaziantep Islam Science and Technology University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nine hole peg test- Single task (time frame: At Baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07150078 | AzTrials